遗传检测市场－全球产业规模、份额、趋势、机会和预测（按疾病类型、按技术、按地区和竞争细分，2020 年至 2030 年）

2024 年全球遗传检测市场价值为 65.4 亿美元，预计到 2030 年将达到 102.6 亿美元，预测期内复合年增长率为 7.79%。遗传检测能够检测、诊断和预防多种遗传疾病，这大大改变了现代医疗保健。这个过程也称为基因或 DNA 检测，涉及检查个人的 DNA 以识别与遗传疾病相关的突变。应用范围包括诊断囊性纤维化和某些癌症等疾病、指导家庭计划以及根据个人基因图谱定製药物疗法。在基因组学和生物技术的快速进步推动下，人们对基因健康的认识不断提高，并推动其广泛应用。除了临床实用性之外，许多消费者还利用遗传检测来探索祖先和了解遗传遗产，促进更广泛的市场扩张。

关键市场驱动因素

遗传疾病盛行率的不断上升推动了全球遗传检测市场的发展

主要市场挑战

道德和隐私问题

主要市场趋势

技术进步

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球基因检测市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依疾病类型（遗传性癌症检测、遗传性非癌症检测）
  • 依技术（细胞遗传学、生化、分子检测）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美基因检测市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲基因检测市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太地区基因检测市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲遗传检测市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲基因检测市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购
• 产品开发
• 最新动态

第 13 章：全球遗传检测市场：SWOT 分析

第 14 章：竞争格局

• Myriad Genetics, Inc.
• Illumina, Inc.
• Natera, Inc.
• Laboratory Corporation of America Holdings
• F. Hoffmann-La Roche Ltd.
• Quest Diagnostics Incorporated
• COOPERSURGICAL, INC.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• SOPHiA GENETICS

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Hereditary Testing Market was valued at USD 6.54 billion in 2024 and is projected to reach USD 10.26 billion by 2030, growing at a CAGR of 7.79% during the forecast period. Hereditary testing has significantly transformed modern healthcare by enabling the detection, diagnosis, and prevention of numerous inherited conditions. Also known as genetic or DNA testing, this process involves examining an individual's DNA to identify mutations linked to hereditary diseases. Applications range from diagnosing conditions like cystic fibrosis and certain cancers to informing family planning and tailoring drug therapies based on individual genetic profiles. The surge in awareness around genetic health, supported by rapid advancements in genomics and biotechnology, is driving widespread adoption. In addition to clinical utility, many consumers are leveraging hereditary testing to explore ancestry and understand genetic heritage, contributing to broader market expansion.

Key Market Drivers

Increasing Prevalence of Genetic Disorders is Driving Global Hereditary Testing Market

The rising incidence of genetic disorders is a primary force behind the growth of the hereditary testing market. As the global population ages, the likelihood of developing hereditary conditions increases, prompting a need for early detection and proactive healthcare. Enhanced research and discovery of genetic markers are broadening the spectrum of diseases for which testing is recommended. Prospective parents are increasingly turning to carrier screening to identify potential hereditary risks to their children, fostering informed reproductive choices. Additionally, genetic testing is gaining traction in assessing susceptibility to hereditary cancers such as breast and colon cancer, enabling timely preventive actions and regular screenings. The expanding understanding of genetics and heightened public awareness are fueling demand for these tests, positioning hereditary testing as a cornerstone of modern personalized medicine.

Key Market Challenges

Ethical and Privacy Concerns

One of the major challenges in the hereditary testing market is the ethical and privacy concerns surrounding genetic data. Individuals are often wary of how their sensitive genetic information is collected, stored, and shared. Risks such as data breaches, unauthorized access, and potential discrimination by employers or insurers create apprehension among users. This has led to increasing calls for stricter data protection laws and transparent policies that ensure confidentiality and responsible usage of genetic information. Addressing these concerns is essential for maintaining public trust and encouraging broader adoption of hereditary testing services.

Key Market Trends

Technological Advancements

The hereditary testing market is being rapidly transformed by technological innovations that are enhancing the speed, affordability, and scope of genetic analysis. One of the most impactful advancements is the widespread adoption of Next-Generation Sequencing (NGS), which allows for efficient and cost-effective sequencing of entire genomes or specific gene panels. This has significantly expanded testing capabilities, making it possible to detect rare mutations and gain deeper insights into genetic predispositions. Additionally, the integration of big data analytics and advanced bioinformatics has revolutionized the interpretation of complex genetic data. These tools enable healthcare providers to identify meaningful patterns and correlations, improving diagnostic accuracy and enabling more precise treatment plans. As these technologies evolve, they are expected to drive further innovation and accessibility in the hereditary testing landscape.

Key Market Players

• Myriad Genetics, Inc.
• Illumina, Inc.
• Natera, Inc.
• Laboratory Corporation of America Holdings
• F. Hoffmann-La Roche Ltd.
• Quest Diagnostics Incorporated
• COOPERSURGICAL, INC.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• SOPHiA GENETICS

Report Scope:

In this report, the Global Hereditary Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hereditary Testing Market, By Disease Type:

• Hereditary Cancer Testing
• Hereditary Non-cancer Testing

Hereditary Testing Market, By Technology:

• Cytogenetic
• Biochemical
• Molecular Testing

Hereditary Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hereditary Testing Market.

Available Customizations:

Global Hereditary Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Hereditary Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Disease Type (Hereditary Cancer Testing, Hereditary Non-cancer Testing)
  • 5.2.2. By Technology (Cytogenetic, Biochemical, Molecular Testing)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Hereditary Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Disease Type
  • 6.2.2. By Technology
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hereditary Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Disease Type
      • 6.3.1.2.2. By Technology
  • 6.3.2. Canada Hereditary Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Disease Type
      • 6.3.2.2.2. By Technology
  • 6.3.3. Mexico Hereditary Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Disease Type
      • 6.3.3.2.2. By Technology

7. Europe Hereditary Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Disease Type
  • 7.2.2. By Technology
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hereditary Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Disease Type
      • 7.3.1.2.2. By Technology
  • 7.3.2. United Kingdom Hereditary Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Disease Type
      • 7.3.2.2.2. By Technology
  • 7.3.3. Italy Hereditary Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Disease Type
      • 7.3.3.2.2. By Technology
  • 7.3.4. France Hereditary Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Disease Type
      • 7.3.4.2.2. By Technology
  • 7.3.5. Spain Hereditary Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Disease Type
      • 7.3.5.2.2. By Technology

8. Asia-Pacific Hereditary Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Disease Type
  • 8.2.2. By Technology
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Hereditary Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Disease Type
      • 8.3.1.2.2. By Technology
  • 8.3.2. India Hereditary Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Disease Type
      • 8.3.2.2.2. By Technology
  • 8.3.3. Japan Hereditary Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Disease Type
      • 8.3.3.2.2. By Technology
  • 8.3.4. South Korea Hereditary Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Disease Type
      • 8.3.4.2.2. By Technology
  • 8.3.5. Australia Hereditary Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Disease Type
      • 8.3.5.2.2. By Technology

9. South America Hereditary Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Disease Type
  • 9.2.2. By Technology
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Hereditary Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Disease Type
      • 9.3.1.2.2. By Technology
  • 9.3.2. Argentina Hereditary Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Disease Type
      • 9.3.2.2.2. By Technology
  • 9.3.3. Colombia Hereditary Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Disease Type
      • 9.3.3.2.2. By Technology

10. Middle East and Africa Hereditary Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Disease Type
  • 10.2.2. By Technology
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Hereditary Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Disease Type
      • 10.3.1.2.2. By Technology
  • 10.3.2. Saudi Arabia Hereditary Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Disease Type
      • 10.3.2.2.2. By Technology
  • 10.3.3. UAE Hereditary Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Disease Type
      • 10.3.3.2.2. By Technology

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Global Hereditary Testing Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Myriad Genetics, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Illumina, Inc.
• 14.3. Natera, Inc.
• 14.4. Laboratory Corporation of America Holdings
• 14.5. F. Hoffmann-La Roche Ltd.
• 14.6. Quest Diagnostics Incorporated
• 14.7. COOPERSURGICAL, INC.
• 14.8. Agilent Technologies, Inc.
• 14.9. Thermo Fisher Scientific, Inc.
• 14.10. SOPHiA GENETICS

15. Strategic Recommendations

16. About Us & Disclaimer